Literature DB >> 20953171

Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme.

Kimie Nakagawa1, Yoshihisa Hirota, Natsumi Sawada, Naohito Yuge, Masato Watanabe, Yuri Uchino, Naoko Okuda, Yuka Shimomura, Yoshitomo Suhara, Toshio Okano.   

Abstract

Vitamin K occurs in the natural world in several forms, including a plant form, phylloquinone (PK), and a bacterial form, menaquinones (MKs). In many species, including humans, PK is a minor constituent of hepatic vitamin K content, with most hepatic vitamin K content comprising long-chain MKs. Menaquinone-4 (MK-4) is ubiquitously present in extrahepatic tissues, with particularly high concentrations in the brain, kidney and pancreas of humans and rats. It has consistently been shown that PK is endogenously converted to MK-4 (refs 4-8). This occurs either directly within certain tissues or by interconversion to menadione (K(3)), followed by prenylation to MK-4 (refs 9-12). No previous study has sought to identify the human enzyme responsible for MK-4 biosynthesis. Previously we provided evidence for the conversion of PK and K(3) into MK-4 in mouse cerebra. However, the molecular mechanisms for these conversion reactions are unclear. Here we identify a human MK-4 biosynthetic enzyme. We screened the human genome database for prenylation enzymes and found UbiA prenyltransferase containing 1 (UBIAD1), a human homologue of Escherichia coli prenyltransferase menA. We found that short interfering RNA against the UBIAD1 gene inhibited the conversion of deuterium-labelled vitamin K derivatives into deuterium-labelled-MK-4 (MK-4-d(7)) in human cells. We confirmed that the UBIAD1 gene encodes an MK-4 biosynthetic enzyme through its expression and conversion of deuterium-labelled vitamin K derivatives into MK-4-d(7) in insect cells infected with UBIAD1 baculovirus. Converted MK-4-d(7) was chemically identified by (2)H-NMR analysis. MK-4 biosynthesis by UBIAD1 was not affected by the vitamin K antagonist warfarin. UBIAD1 was localized in endoplasmic reticulum and ubiquitously expressed in several tissues of mice. Our results show that UBIAD1 is a human MK-4 biosynthetic enzyme; this identification will permit more effective decisions to be made about vitamin K intake and bone health.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20953171     DOI: 10.1038/nature09464

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  25 in total

1.  The metabolic relationships between the different K vitamins and the synthesis of the ubiquinones.

Authors:  C Martius
Journal:  Am J Clin Nutr       Date:  1961 Jul-Aug       Impact factor: 7.045

2.  Menaquinone (vitamin K2) biosynthesis: localization and characterization of the menA gene from Escherichia coli.

Authors:  K Suvarna; D Stevenson; R Meganathan; M E Hudspeth
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

3.  Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4.

Authors:  H H Thijssen; M J Drittij-Reijnders
Journal:  Br J Nutr       Date:  1996-01       Impact factor: 3.718

4.  Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells.

Authors:  Tomoe Ichikawa; Kuniko Horie-Inoue; Kazuhiro Ikeda; Bruce Blumberg; Satoshi Inoue
Journal:  J Biol Chem       Date:  2006-04-10       Impact factor: 5.157

5.  Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4.

Authors:  H H Thijssen; M J Drittij-Reijnders
Journal:  Br J Nutr       Date:  1994-09       Impact factor: 3.718

6.  Genetic analysis of 14 families with Schnyder crystalline corneal dystrophy reveals clues to UBIAD1 protein function.

Authors:  Jayne S Weiss; Howard S Kruth; Helena Kuivaniemi; Gerard Tromp; Jayaprakash Karkera; Sunil Mahurkar; Walter Lisch; William J Dupps; Peter S White; R Scott Winters; Chaesik Kim; Christopher J Rapuano; John Sutphin; Jim Reidy; Fung-Rong Hu; Da Wen Lu; Neil Ebenezer; Michael L Nickerson
Journal:  Am J Med Genet A       Date:  2008-02-01       Impact factor: 2.802

Review 7.  Metabolism and cell biology of vitamin K.

Authors:  Martin J Shearer; Paul Newman
Journal:  Thromb Haemost       Date:  2008-10       Impact factor: 5.249

8.  Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR.

Authors:  Michelle M Tabb; Aixu Sun; Changcheng Zhou; Felix Grün; Jody Errandi; Kimberly Romero; Hang Pham; Satoshi Inoue; Shyamali Mallick; Min Lin; Barry M Forman; Bruce Blumberg
Journal:  J Biol Chem       Date:  2003-08-14       Impact factor: 5.157

9.  Elucidation of the mechanism producing menaquinone-4 in osteoblastic cells.

Authors:  Yoshitomo Suhara; Akimori Wada; Toshio Okano
Journal:  Bioorg Med Chem Lett       Date:  2009-01-11       Impact factor: 2.823

10.  Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy.

Authors:  Andrew Orr; Marie-Pierre Dubé; Julien Marcadier; Haiyan Jiang; Antonio Federico; Stanley George; Christopher Seamone; David Andrews; Paul Dubord; Simon Holland; Sylvie Provost; Vanessa Mongrain; Susan Evans; Brent Higgins; Sharen Bowman; Duane Guernsey; Mark Samuels
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

View more
  108 in total

1.  Vitamin K.

Authors:  John W Suttie; Sarah L Booth
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

2.  The change of the state of cell membrane can enhance the synthesis of menaquinone in Escherichia coli.

Authors:  Yan Liu; Xiu-Min Ding; Zheng-Lian Xue; Liu-Xiu Hu; Ning-Juan Zhang; Zhou Wang; Jian-Wei Yang; Qian Cheng; Ming-Hong Chen; Zhuang-Zhuang Zhang; Zhi-Ming Zheng
Journal:  World J Microbiol Biotechnol       Date:  2017-02-14       Impact factor: 3.312

3.  Bioconversion of farnesol and 1,4-dihydroxy-2-naphthoate to menaquinone by an immobilized whole-cell biocatalyst using engineered Elizabethkingia meningoseptica.

Authors:  Yan Liu; Zi-Ming Yang; Zheng-Lian Xue; Zhou Wang; Shi-Guang Zhao; Long-Bao Zhu; Liu-Xiu Hu; Xiu-Min Ding; Yun Su
Journal:  World J Microbiol Biotechnol       Date:  2017-11-27       Impact factor: 3.312

4.  The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes.

Authors:  Michael L Nickerson; Allen D Bosley; Jayne S Weiss; Brittany N Kostiha; Yoshihisa Hirota; Wolfgang Brandt; Dominic Esposito; Shigeru Kinoshita; Ludger Wessjohann; Scott G Morham; Thorkell Andresson; Howard S Kruth; Toshio Okano; Michael Dean
Journal:  Hum Mutat       Date:  2012-11-27       Impact factor: 4.878

Review 5.  Mechanisms for the prevention of vitamin E excess.

Authors:  Maret G Traber
Journal:  J Lipid Res       Date:  2013-03-15       Impact factor: 5.922

6.  A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine.

Authors:  Matthew G McDonald; Catherine K Yeung; Aaron M Teitelbaum; Amanda L Johnson; Shinya Fujii; Hiroyuki Kagechika; Allan E Rettie
Journal:  J Lipid Res       Date:  2019-01-22       Impact factor: 5.922

Review 7.  Vitamin K and hepatocellular carcinoma: The basic and clinic.

Authors:  Xia Jinghe; Toshihiko Mizuta; Iwata Ozaki
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

8.  Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.

Authors:  Benjamin J Josey; Elizabeth S Inks; Xuejun Wen; C James Chou
Journal:  J Med Chem       Date:  2013-01-30       Impact factor: 7.446

9.  Structural insights into ubiquinone biosynthesis in membranes.

Authors:  Wei Cheng; Weikai Li
Journal:  Science       Date:  2014-02-21       Impact factor: 47.728

10.  UBIAD1-mediated vitamin K2 synthesis is required for vascular endothelial cell survival and development.

Authors:  Jeffrey M Hegarty; Hongbo Yang; Neil C Chi
Journal:  Development       Date:  2013-04       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.